Past Projects


ECOPAINT BIO-BASED FORMULARIONS

 

ASEBIO is participating in the project called “ECOPAINT BIO-BASED FORMULATIONS " within the Capacities program of the Seventh Framework Programme (7FP).

The strategic goal of the project is to use renewable resources for the development of new ecological bio-based solvents which could replace commonly used petrochemical based ones in the Paint and Coatings Industry, maintaining their performance and aesthetical properties but with a reduced carbon footprint, and a brand new alternative of reactive solvent, not emitting VOCs.

The Role of ASEBIO in the project will be related with:

The elaboration of a Plan for the Exploitation and Dissemination of knowledge among the biotech sector in order to establish a dialogue with companies across the value chain to:

  • understand their needs
  • disseminate the project results

Tasks: Supervising the projects results (plan for the use of results / exploitation) / Evaluating the exploitation and training possibilities (agreements between partners) /Disseminating information on the properties and functionalities of the products and by-products obtained / Deciding the ownership of the results and the rights for all the project participants (exploitation agreement)

2) Demonstration activities of the bio-solvents fabrication processes and technologies by identifying suitable SMEs with the capacity to run the scaling-up in industrial facilities to produce a sufficient quantity to test solvent in coatingtrials

The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 605215

 

http://ecobiofor.eu/Home

   

SEACOLORS: Demonstration of new natural dyes from algae as substitution of synthetic dyes actually used by textile industries

 

ASEBIO is participating in the project called "SEACOLORS" within the LIFE+ Environment Policy and Governance of the Seventh Framework Programme (7FP).

SEACOLORS main aim is the demonstration and validation of obtaining natural dyes from a sustainable and renewable source, algae, and their application in textile industry to replace synthetic dyes which are pollutant and harmful for the environment. With this improvement, it will be obtained less contaminated waste water, by the higher biodegradability of natural dyes, reducing the water purification process and contributing to the application of the politics and community legislation regarding waste waters.

The expected results will lead to a substitution in the use of synthetic chemicals by a natural and renewable source, that will turn dyeing into a more ecofriendly and economic procedure.

Our objectives within the project are to disseminate and transfer main project results in order to arrive to the different stakeholders of the project, promoting and raising interest in the project results among the European audience and through European bodies and networks and communicating the opportunities of biotechnology as a promoter for innovation in sectors in which it is less implemented (textile, chemical, waste management, environmental...).

 

With the contribution of the LIFE financial instrument of the European Union (No. LIFE13 ENV/ES/000445).

 

www.seacolors.eu

More info SEACOLORS

BIOTECHNOLOGY 3.0: Biotechnology year in social networks

 

ASEBIO put in motion a new Project called BIOTECNOLOGY 3.0: Biotechnology year in social networks with the collaboration of Spanish Foundation for the Science and Technology- Economy and Competitiveness Minister. The aim of the project is to build an enabling environment based on the knowledge that facilitates the promotion of innovation of the life sciences. This challenge requires the establishment of stable and efficient channels of communication between science and society.

To get this objective, the activities of the project focus on:

1. Generation multistakeholder social debate on various issues of interest to the general public
2. To encourage citizen participation in the activity of dissemination of biotechnology through a contest on social networks
3. Bringing the Spanish research and innovation activity through biotechnology community outreach online, Biotekis.
4. Dissemination biotechnology in Radio

   

PROJECT INVESTBIO

 

With the support of the Industry, Tourism and Trade Ministry of Spain, ASEBIO launches "InvestBio Project: Mobile Application for attracting investors to the biotech sector."

It is a mobile channel application (app) as a digital calendar which will address 365 biotechnology projects.

 

Features:
• Impacts on daily flash format
• Daily digital files with information of biotech projects
• A year-long (app) to coincide with the year of biotechnology(2014)

Register
Two accesses:
• Open access (free) for all audiences
• PREMIUM access (or VIP, restricted to investors with a code-password for further information. Direct contact with staff for questions

 

SPANISH CONFERENCE ON BIOECONOMY

 

On 25th and 26th of September took place The Spanish Conference on Bioeconomy at the Toledo Congress Center.

 

The BIOTIC WORKSHOP of EuropaBio took place on the afternoon before the ASEBIO Bioeconomy Conference on Wednesday 25th September 2013 at the Palacio de Congresos de Toledo. The workshop consist in-depth discussion with a limited number of experts on how to overcome barriers for innovation in Industrial Biotechnology in Europe.

 

"The Spanish Conference on Bioeconomy" consisted of a multistakeholder discussion forum where we will share the needs and technology offerings that will promote the future of the bioeconomy in Spain, in line with the programme and European targets presented in the Communication 13-2 -2012 [COM (2012)] and the Horizon 2020.

 

More info

Register:

BIOTIC FORUM http://tinyurl.com/biotic-spain

SPANISH CONFERENCE ON BIOECONOMY: Send an email: bpalomo@asebio.com or calling ASEBIO +034 912109374

   

SUMMA Project: Identification of early and aggregated demand of technologies in the field of personalised medicine (advanced markers) in the National Health System

 

Many of the companies which make up ASEBIO develop hi-tech products and services in the field of personalised medicine. Particularly in the area of new markers (predisposition, risk, diagnosis, prognosis, choice and response to treatment, etc.) that are being discovered by using high-throughput analysis technologies (genomics, proteomics, transcriptomics, metabolomics ... etc), which will be referred to as advanced markers, a powerful tool for moving towards more efficient and cost-effective medicine.

 

These technologies are changing the biopharmaceutical business model, towards a more open environment, with greater opportunities for innovative companies. This new scenario is, particularly in the case of the Spanish economy, a clear opportunity for the generation of wealth and employment. We have strengths like our National Health System, scientific and clinical excellence and a very dynamic biotech industry, which will lead to a definitive increase in "local market access" by international customers to validate the available products and services and mobilize investment for future development. 

 

ASEBIO has launched the SUMMA project in collaboration with Avantia XXI, and with the support of Merck, REGIC and the Ministry of Industry, Trade and Tourism through the "innovative clusters program", for the purpose of:

 

  • Gaining a better understanding of  the perceptions of clinicians and health managers on these developments and their implementation in the National Health System
  • Identifying possible areas of development of new product categories that address unmet needs in two areas: oncology and haematology; in which the use of these technologies are initiators are being pioneers
  • Testing the interest for multiple technologies which have already been developed or are under development in Spain

 

The main focus of this project is aimed at establishing adequate communication channels between public demand and private provision. To this end, a survey will be carried out to determine the perceptions of health policy-makers, hospital managers and opinion leaders in oncology and haematology regarding the maturity and degree of penetration of these technologies, their impact and cost effectiveness.

 

It will also seek to assess the respondents' knowledge of, and interest in, the possible use of these innovative instruments to promote innovation in public demand (innovative public procurement), which is one of the priorities adopted by the European Union (Horizon 2020), the Government of Spain and regional governments in their R&D policies.   

 

It is all aimed at identifying unmet needs and future development opportunities, in both areas, based on products and services currently available in the market. It is a technology forecasting exercise aimed at identifying early and aggregated demand for technology by the Spanish National Health System to facilitate the alignment of research efforts by companies and institutions with the perceived needs of clinicians.

 

Thus, by identifying strategies for dialogue and collaboration between the National Health System and the companies that make up the Spanish biotechnology business community, we hope to establish the foundations for recovery, promote development, the generation of new knowledge and encourage companies to maximise their market and their future internationalisation.

 

For this reason ASEBIO will hold various business meetings to define the needs and interests of our national health system and to establish joint collaborative projects between administrations, so that businesses and government work in the same direction, resolving current problems and helping our health system to reassert itself as a service of excellence in healthcare.

   

Spanish Biotech Platform

 

In 2010 was set in motion the Spanish Biotech Platform launched by ASEBIO and supported by the MINECO- the Ministry of Economy and Competitiveness. The goal of the Spanish Biotech Platform is to develop steady, efficient and multilateral channels of communication between the different agents in the science-technology-company system, in order to foster biotechnological innovation, technology transfer and its expansion to our society by capitalising on its socioeconomic, environmental and health benefits.

 

The Platform has a Technical Secretariat composed of staff ASEBIO, which is leading the proceedings, and collaborates with various institutions that are part of it. It also has a Management Council and Advisory Committee to assist in advocacy and representation and in advising the Platform in its initiatives.

More information in: http://www.mercadosbiotecnologicos.com/en/index.cfm

   
Plan of strategic action

Plan of strategic action


The Spanish Bioindustry Association, with the support of the Ministry of Industry, Tourism and Trade of Spain, has developed a plan of strategic action to turn itself into an Innovative Enterprise Group (AEI). The activities done in the past are a diagnosis of the situation of the national and international biotechnological sector and define strategies and plans of action to become an AEI.

   
Plan de actuación Estratégico

Bio-stimulate: Public Purchase of Biotechnology Innovative Technology


ASEBIO with the colaboration of the Foundation COTEC, has started the project Bio-stimulate, whose final aim is elaborating the "White Book on the Public Purchase of Biotechnology Innovative Technology".


This book is only available in spanish.

   
Program Eureka

European Markets and Spain: Strategies of collaboration and technological joint development in biotechnology (Program Eureka)


ASEBIO has initiated with the support of the Spanish Technological Industrial Development Center (CDTI) the project "European Markets and Spain: Strategies of collaboration and technological joint development in biotechnology (Program Eureka)" which identifies dialogue strategies and joint business collaboration between the biotechnological companies of several European countries (Switzerland, Germany, Israel, United Kingdom) and Spain. ASEBIO and several European associations and national innovation agencies will stimulate the joint participation in the European R&D space area and more concretely in the Eureka and Eurostars programmes.


With this purpose, ASEBIO will follow several business meetings, mainly in the International Biotechnology Congress BIOSPAIN 2010 (Pamplona, 29 sept-1 oct) in order to define common interests and collaborative projects.

   
Your Biotech Home

Your Biotech Home


ASEBIO, with the support of the Foundation for the Science and the Technology (FECYT) and the collaboration of MERCK, AMGEN and FERRER IN CODE, has started a new and innovative initiative for the popularisation of the biotechnology: the exhibition "Your Biotech Home".


"Your Biotech Home" lets the visitor discover that the biotechnology is already present in our daily life, through a domestic environment where different contributions, products and biotechnological processes that belong to our life can be exhibited.


"Your Biotech Home" will be located in different Spanish localities. More than 10.000 people have already enjoyed the exhibition in Madrid in the Museum Cosmocaixa (April 4th to April 12th) and in Salamanca during the First Biotechnology Week (April 20th to April 24th).

 

 

View images

   
Unit of International Innovation

Unit of International Innovation of ASEBIO


ASEBIO sets in motion a Unit of International Innovation (UII) with the CDTI support, with the purpose to promote the participation in the VII Programme Framework and to support in the internationalisation of the R&D from different companies of the Spanish biotech sector.


This Unit will permit to attend and to assess in the formation of the consortiums, quality proposals preparation and negotiation with the European Commission to maximise the European financing in R&D projects from the ASEBIO companies.


Likewise, this Unit will offer aid to the companies to get the public financing (The MITyC and MEC assemblies, Autonomous Communities or APC + of the CDTI), and to detect new European consortiums in formation process to enlarge the participation possibilities.


http://cordis.europa.eu/fp7/dc/index.cfm

   
Report about trends on Biological Products

Report about trends on Biological Products


This report has been elaborated in collaboration with the Politechnical University of Madrid, joins the V Foro University - company 2008.


With this forum, promoted by the UPM and by the Council of Economy of the Community of Madrid, the Community of Madrid can identify those sectors with potential development and that could be interesting to foment. In addition, this Forum represents a good opportunity to present the worries and needs of the managerial fabric of the CM, included the biotechnological one.

   
INNOEMPRESA

The Biotechnology as a vector of competitiveness in traditional sectors (INNOEMPRESA)


ASEBIO, with the support of the MITYC, set in motion an ambitious biotech applications diffusion programme in SMEs of the Spanish traditional industry sectors to offer "bio-solutions" relating to: Bioprocess (chemical, textile, foodstuff, pharmacy etc), quality control technologies, security and traceability based on biotechnology and ingredients and functional allegations (foodstuff, cosmetic, etc).


A technological advisors network was established, conformed by associated companies to ASEBIO, which carried out 75 technological diagnoses. Said diagnostics described exhaustively the aspects of a traditional SME that was object of improvement by means of the biotechnology.

   
II Spanish Forum of Bioregions

II Spanish Forum of Bioregions


ASEBIO and the State Company for the Attraction and Promotion of the Exterior Investments (INTERES Invest in Spain) celebrated the "II Spanish Forum of Bioregions", which in this edition included the contribution of Biocat - Bioregió of Catalunya and Barcelona Activa. Under the title "Experiences exchange of Clusters Biotech", this forum met the main responsible of the central and autonomous administrations, interface companies, and environment R&D+i that head it set in motion of bioclusters in Spain, for exchanging experiences and agreeing to different cases of international success in public politics of support to the biotech sector.


[ + info ]
   
European project of Good Bioethical Practices

European project of Good Bioethical Practices


ASEBIO participates in the European project on Good Bioethical Practices "From GMP to GBP: Fostering Good Bioethical Practices (GBP) among European Biotechnology Industry" prompted by France Biotech, Europabio and other companies. This project implies to biotechnology companies of Estonian, Hungary, Spain, Sweden and France and with it expects to improve the comprehension of the bioethical using the biotech companies daily practice. The results will contribute to define a methodology for the evaluation of these practices and facilitate the connection between industry, authorities and society.


[ + info ]
   
RedBio

RedBio


The objective of this project is establishing an encounter platform that permit working of coordinated form to different agents implied in the development of the Spanish biotech sector. RedBio is an initiative promoted by ASEBIO, the Spanish Bioindustry Association and in which participate besides three regional business organizations (CATALONIABIO, BIOMADRID and BIOVAL) and a scientific society (SEBIOT).

Developed by Web4Bio